PuSH - Publication Server of Helmholtz Zentrum München

141 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
41.
Gao, Y. et al.: Disruption of lipid uptake in astroglia exacerbates diet induced obesity. Diabetes 66, 2555-2563 (2017)
42.
Heni, M. et al.: Hypothalamic and striatal insulin action suppresses endogenous glucose production and may stimulate glucose uptake during hyperinsulinemia in lean but not in overweight men. Diabetes 66, 1797-1806 (2017)
43.
Kabra, U.D. et al.: Direct substrate delivery into mitochondrial-fission deficient pancreatic islets rescues insulin secretion. Diabetes 66, 1247-1257 (2017)
45.
Klement, J.* et al.: Oxytocin improves beta-cell responsivity and glucose tolerance in healthy men. Diabetes 66, 264-271 (2017)
46.
Krischer, J.P.* et al.: The influence of type 1 diabetes genetic susceptibility regions, age, sex, and family history to the progression from multiple autoantibodies to type 1 diabetes: A TEDDY Study Report. Diabetes 66, 3122-3129 (2017)
47.
Lee, K.Y.* et al.: Tbx15 defines a glycolytic subpopulation and white adipocyte heterogeneity. Diabetes 66, 2822-2829 (2017)
48.
Manning, A.* et al.: A low-frequency inactivating Akt2 variant enriched in the Finnish population is associated with fasting insulin levels and type 2 diabetes risk. Diabetes 66, 2019-2032 (2017)
49.
Rodriguez-Calvo, T. ; Atkinson, M.* & Von Herrath, M.G.*: Response to comment on Rodriguez-Calvo et al. Increase in pancreatic proinsulin and preservation of β-cell mass in autoantibody-positive donors prior to type 1 diabetes onset. diabetes 2017;66:1334-1345. Diabetes 66, e10-e11 (2017)
50.
Rodriguez-Calvo, T. ; Atkinson, M.* & Von Herrath, M.G.*: Response to comment on Rodriguez-Calvo et al. Increase in pancreatic proinsulin and preservation of β-cell mass in autoantibody-positive donors prior to type 1 diabetes onset. Diabetes 2017;66:1334–1345. Diabetes 66, e10-e11 (2017)
51.
Scerbo, M.J. & Gerdes, J.M.: Bonding with beta-cells-a role for oxytocin in glucose handling. Diabetes 66, 256-257 (2017)
52.
Scott, R.A.* et al.: An expanded genome-wide association study of type 2 diabetes in Europeans. Diabetes 66, 2888-2902 (2017)
53.
Tschöp, M.H. & DiMarchi, R.*: Single-molecule combinatorial therapeutics for treating obesity and diabetes. In:. Alexandria: Amer Diabetes Assoc, 2017. 1766-1769 (Diabetes ; 66)
54.
Ussar, S. et al.: Regulation of glucose uptake and enteroendocrine function by the intestinal epithelial insulin receptor. Diabetes 66, 886-896 (2017)
55.
Varela, L.* et al.: Endothelial HIF-1α enables hypothalamic glucose uptake to drive POMC neurons. Diabetes 66, 1511-1520 (2017)
56.
Wagner, R. et al.: Nonsuppressed glucagon after glucose challenge as a potential predictor for glucose tolerance. Diabetes 66, 1373-1379 (2017)
57.
Wolf, K. et al.: Erratum. Association between long-term exposure to air pollution and biomarkers related to insulin resistance, subclinical inflammation, and adipokines (vol 65, pg 3314, 2016). Diabetes 66, 2725-2725 (2017)
58.
Wood, A.R.* et al.: A genome-wide association study of IVGTT-based measures of first-phase insulin secretion refines the underlying physiology of type 2 diabetes variants. Diabetes 66, 2296-2309 (2017)
59.
Adam, J. et al.: Metformin effect on non-targeted metabolite profiles in patients with type 2 diabetes and multiple murine tissues. Diabetes 65, 3776-3785 (2016)
60.
Böhm, A. et al.: TGFβ contributes to impaired exercise response by suppression of mitochondrial key regulators in skeletal muscle. Diabetes 65, 2849-2861 (2016)